Skip to content

US · HIMS · MEDICAL - EQUIPMENT & SERVICES

Hims & Hers Health, Inc. (HIMS) intrinsic value and stock valuation

$14.60as of 2026-11-21 · Mkt cap 7.06B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Hims & Hers Health, Inc. DCF and intrinsic value

InvestorsCraft values HIMS with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from HIMS’s statements →

Hims & Hers Health, Inc. Graham Number

Graham Number: $5.56d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Equipment & Services San Francisco, CA 94123 hims.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$2.35B+73.6% 5y CAGRd
20192025
Net income
$128.4M
20192025
Free cash flow
$74M
20192025
Total equity
$540.9M
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$2.35B$1.48B$872M$526.9M$271.9M
Operating income$105.6M$61.9M-$-29.45M-$-68.7M-$-115.04M
Net income$128.4M$126M-$-23.55M-$-65.68M-$-107.66M
EPSd$497.1K$532.2K-$-112.5K-$-321.14K-$-576.4K
Operating cash flow$300M$251.1M$73.5M-$-26.53M-$-34.41M
Capital expenditure-$-226.04M-$-52.75M-$-26.49M-$-7.25M-$-5.01M
Free cash flow$74M$198.3M$47M-$-33.78M-$-39.42M
Total assets$2.15B$707.5M$441.2M$366.3M$420.6M
Total debt$1.12B$11.4M$9.95M$5.31M$5.48M
Net debt$892M-$-209.24M-$-86.72M-$-41.47M-$-66.3M
Total equity$540.9M$476.7M$344M$311.7M$334.6M
Cash and short-term investments$577.5M$300.3M$221M$179.6M$247.3M
Income statement
20252024202320222021
Revenue$2.35B$1.48B$872M$526.9M$271.9M
Cost of revenue$614.3M$303.4M$157.1M$118.2M$67.4M
Gross profit$1.73B$1.17B$715M$408.7M$204.5M
Research and development expenses$149.3M$78.8M$48.2M$29.2M$22.4M
Selling, general and administrative expenses$1.19B$846.6M$576.3M$370.8M$249.6M
Other expenses$286.4M$185.8M$119.9M$77.4M$47.6M
Operating expenses$1.63B$1.11B$744.4M$477.4M$319.5M
Cost and expenses$2.24B$1.41B$901.5M$595.6M$386.9M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$54.5M$17.1M$9.52M$7.47M$4.08M
Ebitda$178.4M$88.8M-$-12.06M-$-58.23M-$-106.72M
Operating income$105.6M$61.9M-$-29.45M-$-68.7M-$-115.04M
Total other income/expenses, net$18.3M$9.81M$7.88M$2.99M$4.25M
Income before tax$123.9M$71.7M-$-21.57M-$-65.71M-$-110.8M
Income tax expense-$-4.44M-$-54.33M$1.98M-$-30K-$-3.14M
Net income$128.4M$126M-$-23.55M-$-65.68M-$-107.66M
Weighted average shares outstanding$225M$215.9M$209.3M$204.5M$186.8M
Weighted average diluted shares outstanding$258.2M$236.8M$209.3M$204.5M$186.8M
Balance sheet
20252024202320222021
Cash and short-term investments$577.5M$300.3M$221M$179.6M$247.3M
Net receivables$32.2M$6.08M$6.75M$3.23M$3.58M
Inventory$115.7M$64.4M$22.5M$21.6M$13.6M
Total current assets$767.6M$395.8M$265.1M$216.6M$269.9M
Property, plant and equipment, net$449M$93M$45.7M$16.1M$5.11M
Goodwill and intangible assets$474.4M$156.1M$129.5M$132.7M$136.8M
Long-term investments$351.3M$0.00$0.00$0.00$0.00
Total non-current assets$1.39B$311.7M$176.1M$149.8M$150.7M
Total assets$2.15B$707.5M$441.2M$366.3M$420.6M
Accounts payable$143.3M$91.2M$43.1M$32.4M$19.6M
Short-term debt$4.84M$1.89M$1.28M$1.66M$1.36M
Deferred revenue$127.2M$75.3M$7.73M$1.47M$3.19M
Total current liabilities$404.4M$221.4M$88.5M$47.9M$79.2M
Long-term debt$1.12B$9.46M$8.67M$3.65M$4.12M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.21B$9.46M$8.69M$6.66M$6.75M
Capital lease obligations$148M$11.4M$9.95M$5.31M$5.48M
Total liabilities$1.61B$230.8M$97.2M$54.6M$86M
Common stock$20K$20K$20K$20K$20K
Retained earnings-$-113.77M-$-242.14M-$-368.18M-$-344.63M-$-278.95M
Accumulated other comprehensive income (loss)$2.29M-$-320K-$-120K-$-280K-$-140K
Total equity$540.9M$476.7M$344M$311.7M$334.6M
Total investments$700.1M$79.7M$124.3M$132.9M$175.5M
Total debt$1.12B$11.4M$9.95M$5.31M$5.48M
Net debt$892M-$-209.24M-$-86.72M-$-41.47M-$-66.3M
Cash flow statement
20252024202320222021
Net income$128.4M$126M-$-23.55M-$-65.68M-$-107.66M
Depreciation and amortization$54.5M$17.1M$9.52M$7.47M$4.08M
Stock-based compensation$135.2M$92.3M$66.1M$42.8M$67.2M
Change in working capital-$-29.16M$78.6M$20.8M-$-14.2M$3.46M
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory-$-13.72M-$-41.61M-$-900K-$-8M-$-9.63M
Accounts payable$30.3M$43.7M$7.32M$12.7M$9.85M
Net cash provided by operating activities$300M$251.1M$73.5M-$-26.53M-$-34.41M
Investments in property, plant and equipment-$-226.04M-$-41.66M-$-17.22M-$-2.71M-$-830K
Acquisitions, net-$-145.23M-$-15.4M$0.00-$-460K-$-46.47M
Net cash used for investing activities-$-1.02B-$-19.05M-$-12.11M$34.7M-$-156.27M
Common stock issued$17.5M$0.00$0.00$0.00$272.7M
Common stock repurchased-$-89.96M-$-83.04M-$-2M$0.00-$-22.03M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$729.6M-$-107.84M-$-11.47M-$-33.13M$235M
Net change in cash$8.03M$123.9M$49.9M-$-25.01M$44.3M
Cash at end of period$228.6M$221.4M$97.5M$47.6M$72.6M
Operating cash flow$300M$251.1M$73.5M-$-26.53M-$-34.41M
Capital expenditure-$-226.04M-$-52.75M-$-26.49M-$-7.25M-$-5.01M
Free cash flow$74M$198.3M$47M-$-33.78M-$-39.42M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Hims & Hers Health, Inc.

        Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

        CEO
        Andrew Dudum
        Employees
        2.44K
        Beta
        2.34

        Explore

        Frequently asked questions

        What is the intrinsic value of Hims & Hers Health, Inc. (HIMS)?

        Hims & Hers Health, Inc. (HIMS) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is HIMS undervalued?

        HIMS trades at a price of $14.60 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.